Treatment of benign prostate enlargement BPH with matra basti or uttar basti with sahacharadi taila.

Efficacy of Uttar Basti and Matra Basti with Sahacharadi Taila along with Varunashigravadi Ghanavati in the management of Mootraghata (Benign Prostatic Hyperplasia) – An open labelled randomised comparative clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/051180

Enrollment

Registered

2023-03-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N398- Other specified disorders of urinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The patients having 3 or more than 3 signs and symptoms of Mootraghata (Benign Prostatic Hyperplasia) Incomplete emptying Frequency Intermittency Urgency Weak stream Straining Nocturia

Exclusion criteria

Exclusion criteria: 1.Patients of age below 40 years and above 70 years. 2.Patients of malignancy, congenital deformities of urogenital tract or any abdominal-pelvic pathology other than BPH. 3.Systemic diseases like chronic renal failure (CRF), Uncontrolled Hypertension (BP >150/90 mmHg), diabetes mellitus (RBS >140 mg/dl), 4.Patients having Hematuria (Blood in the urine), Bladder infection (UTI), kidney stone, Bladder stones. 5.Patient of k/c/o Tuberculosis, Paralysis, and Parkinsonism will be excluded. 6.Known case of cardiac diseases (H/O- MI, IHD). 7.Patient having HIV, HBsAg, HCV, VDRL positive.

Design outcomes

Primary

Measure	Time frame
Relief in feature of MootraghatTimepoint: 3 Week	—

Secondary

Measure	Time frame
Quality of life styleTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDR T S DUDHAMAL

ITRA

DRTSDUDHAMAL@GMAIL.COM9428671939

Outcome results